RNA delivery systems.
作者信息
Bhatia Sangeeta N, Dahlman James E
机构信息
Harvard University-Massachusetts Institute of Technology Division of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139.
Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02139.
出版信息
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2315789121. doi: 10.1073/pnas.2315789121. Epub 2024 Mar 4.
Abstract
摘要
相似文献
1
RNA delivery systems.RNA递送系统。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2315789121. doi: 10.1073/pnas.2315789121. Epub 2024 Mar 4.
2
Advanced nanoscale delivery systems for mRNA-based vaccines.用于基于mRNA的疫苗的先进纳米级递送系统。
Biochim Biophys Acta Gen Subj. 2024 Mar;1868(3):130558. doi: 10.1016/j.bbagen.2024.130558. Epub 2024 Jan 5.
3
In vivo application of RNA interference: from functional genomics to therapeutics.RNA干扰的体内应用：从功能基因组学到治疗学
Adv Genet. 2005;54:117-42. doi: 10.1016/S0065-2660(05)54006-9.
4
Protein-based delivery systems for RNA delivery.基于蛋白质的 RNA 递释系统。
J Control Release. 2023 Nov;363:253-274. doi: 10.1016/j.jconrel.2023.09.032. Epub 2023 Sep 28.
5
Delivery Systems for RNA Interference Therapy: Current Technologies and Limitations.RNA 干扰疗法的递药系统：现有技术与局限。
Curr Gene Ther. 2020;20(5):356-372. doi: 10.2174/1566523220666201005110726.
6
Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics.聚合物纳米颗粒递药系统在 RNA 治疗中的进展。
Prog Mol Biol Transl Sci. 2024;204:219-248. doi: 10.1016/bs.pmbts.2024.01.001. Epub 2024 Jan 30.
7
Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.用于基于蛋白质、DNA和RNA的疫苗的粘膜佐剂和递送系统。
Immunol Cell Biol. 2004 Dec;82(6):617-27. doi: 10.1111/j.1440-1711.2004.01288.x.
8
Lipids and Lipid Derivatives for RNA Delivery.用于 RNA 递送的脂质和脂质衍生物。
Chem Rev. 2021 Oct 27;121(20):12181-12277. doi: 10.1021/acs.chemrev.1c00244. Epub 2021 Jul 19.
9
Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.纳米颗粒给药系统用于 DNA/RNA 及其在纳米医学中的潜在应用。
Curr Top Med Chem. 2019;19(27):2507-2523. doi: 10.2174/1568026619666191024170212.
10
RNA interference-based therapy and its delivery systems.基于 RNA 干扰的治疗及其递药系统。
Cancer Metastasis Rev. 2018 Mar;37(1):107-124. doi: 10.1007/s10555-017-9717-6.
引用本文的文献
1
Nanoparticle Targeting Strategies for Lipid and Polymer-Based Gene Delivery to Immune Cells In Vivo.用于基于脂质和聚合物的基因体内递送至免疫细胞的纳米颗粒靶向策略
Small Sci. 2024 Jul 30;4(9):2400248. doi: 10.1002/smsc.202400248. eCollection 2024 Sep.
2
MicroRNAs in the Mitochondria-Telomere Axis: Novel Insights into Cancer Development and Potential Therapeutic Targets.线粒体-端粒轴中的微小RNA：对癌症发展的新见解及潜在治疗靶点
Genes (Basel). 2025 Feb 25;16(3):268. doi: 10.3390/genes16030268.
3
Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles.脂质纳米颗粒中新型辅料使用的化学、生产和控制策略。
Nat Nanotechnol. 2025 Mar;20(3):331-344. doi: 10.1038/s41565-024-01833-9. Epub 2025 Jan 16.
4
Current Non-Viral-Based Strategies to Manufacture CAR-T Cells.当前基于非病毒的嵌合抗原受体T细胞制造策略。
Int J Mol Sci. 2024 Dec 21;25(24):13685. doi: 10.3390/ijms252413685.
本文引用的文献
1
Thiophene-based lipids for mRNA delivery to pulmonary and retinal tissues.基于噻吩的脂质用于向肺部和眼部组织递送 mRNA。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307813120. doi: 10.1073/pnas.2307813120. Epub 2024 Mar 4.
2
Recent advances in nanoparticulate RNA delivery systems.纳米颗粒 RNA 递释系统的最新进展。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307798120. doi: 10.1073/pnas.2307798120. Epub 2024 Mar 4.
3
Targeted nonviral delivery of genome editors in vivo.体内靶向非病毒基因编辑载体的递送。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307796121. doi: 10.1073/pnas.2307796121. Epub 2024 Mar 4.
4
Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system.利用 RNAi 和肽类递药系统靶向和监测卵巢癌侵袭。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307802121. doi: 10.1073/pnas.2307802121. Epub 2024 Mar 4.
5
Endosomal escape: A bottleneck for LNP-mediated therapeutics.内涵体逃逸：LNP 介导治疗的瓶颈。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307800120. doi: 10.1073/pnas.2307800120. Epub 2024 Mar 4.
6
Human paraneoplastic antigen Ma2 (PNMA2) forms icosahedral capsids that can be engineered for mRNA delivery.人副肿瘤抗原 Ma2（PNMA2）形成二十面体衣壳，可用于 mRNA 递送的工程改造。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307812120. doi: 10.1073/pnas.2307812120. Epub 2024 Mar 4.
7
Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes.脂质纳米颗粒的结构和在怀孕期间的输送途径决定了 mRNA 的效力、免疫原性以及母婴结局。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307810121. doi: 10.1073/pnas.2307810121. Epub 2024 Mar 4.
8
Dynamic carriers for therapeutic RNA delivery.治疗性 RNA 递送的动态载体。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307799120. doi: 10.1073/pnas.2307799120. Epub 2024 Mar 4.
9
Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies.聚阴离子通过静电吸附作用被脂质纳米粒摄取，控制 RNA 和 DNA 治疗药物的摄取、转染和运输。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307809121. doi: 10.1073/pnas.2307809121. Epub 2024 Mar 4.
10
A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles.一种用于分离和表征脂质纳米粒生物分子冠的磁分离方法。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307803120. doi: 10.1073/pnas.2307803120. Epub 2024 Mar 4.
Zotero 插件